Cognizant Tech Solns (NASDAQ:CTSH) has received mixed analyst ratings over the past quarter, with 12 analysts offering diverse opinions. The average 12-month price target is $74.83, up from the previous $73.00, with a high estimate of $90.00 and a low of $65.00. Analysts from firms like Barclays, Citigroup, and Jefferies have raised their price targets, while others from BMO Capital, JP Morgan, and Morgan Stanley have lowered theirs. Cognizant's financial performance shows a positive revenue trend, an impressive net margin, and strong ROA, but a below-average ROE and a conservative debt-to-equity ratio.